Cancer management remains in focus at SKIMS Conference; Institute plans to establish Integrated Cell & Gene Therapy Centre

STC NEWS DESK
SRINAGAR, APRIL 11 (STC): Sher-i-Kashmir Institute of Medical Sciences (SKIMS) is creating a collaborative platform for conducting research in cancer therapeutics with the long term vision of establishing ‘Integrated Cell and Gene Therapy Centre’ at the Institute. The Centre would be the first of its kind not only in this region but in the whole country. This initiative would go in a long run for developing newer treatment strategies for cancer management and would immensely benefit the cancer patients.
In this regard, a meeting was convened by SKIMS Research Cell between Dr. Khalid Shah, Director SKIMS and Senior Faculty Members. It’s pertinent to mention that the meeting was held in the backdrop of CME & Research Orientation Program organised by SKIMS- NAMS & SKIMS Research Cell.
Remarkably, Dr. Khalid Shah, a leading expert in cancer biology and translational therapies, in his lecture has emphasized the importance of interdisciplinary collaboration, innovative research methodologies, engineered cell therapies and emerging technologies in advancing brain tumor treatment.
Dr Shah is Vice Chair of Research, Department of Neurosurgery and Director, Center for Stem Cell and Translational Immunotherapy, Brigham and Women’s Hospital and Professor, Harvard Medical School, USA.
He delivered an inspiring lecture on ‘Role of Cellular and Gene therapy in Brain Tumor Therapeutics’ at a CME & Research Orientation Program organised by SKIMS- NAMS & SKIMS Research Cell.
He highlighted recent breakthroughs, including immunotherapies and precision medicine approaches, that are reshaping the future of neuro-oncology. “The fight against brain tumors requires a global, collaborative effort—combining cutting-edge science with clinical insights to develop transformative therapies,” said Dr. Shah.
“By fostering international partnerships across disciplines, we can accelerate progress and bring hope to patients within the region, country and worldwide,” he said
Meanwhile, the session also featured an interactive Q&A session, where participants exchanged ideas on challenges in cancer management, funding opportunities for cutting edge research, and collaboration. Attendees praised Dr. Shah’s visionary perspective and his commitment to translating lab discoveries into real-world therapies and his dream to bring those recently developed treatment options to his hometown.(STC)